Cogent Biosciences
COGT
COGT
148 hedge funds and large institutions have $1.02B invested in Cogent Biosciences in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+2
Holders Change %
+1.37%
% of All Funds
2.15%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
28
Increased
54
Reduced
47
Closed
23
Calls
$1.68M
Puts
$1.91M
Net Calls
-$229K
Net Calls Change
-$861K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
$88.3M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
$30.6M |
| 3 |
CC
Commodore Capital
New York
|
$82.1M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
$35.8M |
| 5 |
DM
Deerfield Management
New York
|
$31.6M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
$32.3M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
$133K |
| 3 |
Millennium Management
New York
|
$10.4M |
| 4 |
Morgan Stanley
New York
|
$8.28M |
| 5 |
PA
Perceptive Advisors
New York
|
$0 |
